GLENMARK PHARMACEUTICALS
|
The Current P/S Ratio of GLENMARK PHARMACEUTICALS is 4.70.
Share Price | ₹2,218.2 | Jul 14,2025 |
Market Cap | ₹62,597.6 Cr | |
Sales-TTM | ₹13,321.7 Cr | TTM-Consolidated Results |
Price/Sales | 4.70x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of GLENMARK PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹62,597.6 Cr] as on Jul 14,2025
(/) Sales [ ₹13,321.7 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 4.70x ]
Thus, for GLENMARK PHARMACEUTICALS , the investors are currently willing to pay '4.70 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of GLENMARK PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of GLENMARK PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of GLENMARK PHARMACEUTICALS
PS Ratio Performance Analysis for GLENMARK PHARMACEUTICALS
- GLENMARK PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.24x.
- GLENMARK PHARMACEUTICALS 's operated at median p/e ratio of 1.13x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GLENMARK PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 2.29x.
- GLENMARK PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 0.55x.
How does GLENMARK PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
GLENMARK PHARMACEUTICALS | 13,321.7 | 4.70 | 62,597.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 52,578.4 | 7.68 | 403,580.0 |
DIVIS LABORATORIES LTD | 9,360.0 | 19.24 | 180,069.0 |
CIPLA LTD | 27,547.6 | 4.35 | 119,919.0 |
TORRENT PHARMACEUTICALS LTD | 11,516.0 | 10.01 | 115,310.0 |
DR REDDYS LABORATORIES LTD | 32,643.9 | 3.20 | 104,402.0 |
MANKIND PHARMA LTD | 12,279.3 | 9.07 | 111,429.0 |
ZYDUS LIFESCIENCES LTD | 23,241.5 | 4.19 | 97,453.8 |
LUPIN LTD | 22,707.9 | 3.87 | 87,906.4 |
AUROBINDO PHARMA LTD | 31,723.7 | 2.08 | 66,141.7 |
ABBOTT INDIA LTD | 6,409.2 | 11.40 | 73,073.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GLENMARK PHARMACEUTICALS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.08x |
Max industry PS | 19.24x |
Median industry PS | 4.70x |
Average industry PS | 7.25x |
You may also like the below Video Courses